| scholarly article | Q13442814 |
| P50 | author | Simon Iain Hay | Q15994492 |
| Morteza Shamsizadeh | Q59591758 | ||
| Jennifer M. Ross | Q61161790 | ||
| Benn Sartorius | Q64952391 | ||
| David M. Pereira | Q37607476 | ||
| Maysaa El Sayed Zaki | Q37607512 | ||
| P2093 | author name string | GBD Tuberculosis Collaborators | |
| P2860 | cites work | Global, regional, and national incidence and mortality for HIV, tuberculosis, and malaria during 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013. | Q21034169 |
| Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010 | Q21534928 | ||
| Screening strategies for active tuberculosis: focus on cost-effectiveness | Q26740226 | ||
| The WHO's new End TB Strategy in the post-2015 era of the Sustainable Development Goals | Q26765399 | ||
| Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013. | Q26782024 | ||
| Global, regional, and national incidence, prevalence, and years lived with disability for 310 diseases and injuries, 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015 | Q27468570 | ||
| Quality of tuberculosis care in high burden countries: the urgent need to address gaps in the care cascade | Q28071919 | ||
| TB as a cause of hospitalization and in-hospital mortality among people living with HIV worldwide: a systematic review and meta-analysis | Q28073480 | ||
| Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013 | Q28083357 | ||
| Incidence of serious side effects from first-line antituberculosis drugs among patients treated for active tuberculosis | Q28207601 | ||
| The prognosis of a positive tuberculin reaction in childhood and adolescence | Q28245795 | ||
| The population dynamics and control of tuberculosis | Q28282446 | ||
| Performance of the Tariff Method: validation of a simple additive algorithm for analysis of verbal autopsies | Q28741087 | ||
| Global, regional, and national disability-adjusted life-years (DALYs) for 315 diseases and injuries and healthy life expectancy (HALE), 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015. | Q30061930 | ||
| Design options for sample-based mortality surveillance. | Q30350758 | ||
| Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980-2015: a systematic analysis for the Global Burden of Disease Study 2015. | Q30353189 | ||
| Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks, 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015. | Q30353195 | ||
| Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks in 188 countries, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013 | Q30358426 | ||
| Time delays in diagnosis of pulmonary tuberculosis: a systematic review of literature | Q30865343 | ||
| The association between alcohol use, alcohol use disorders and tuberculosis (TB). A systematic review | Q30955276 | ||
| Risk factors for tuberculosis | Q59032574 | ||
| Four steps to precision public health | Q59065026 | ||
| Tuberculosis in older adults in the United States, 1993-2008 | Q64128369 | ||
| Initial defaulting in the National Tuberculosis Programme in Ho Chi Minh City, Vietnam: a survey of extent, reasons and alternative actions taken following default | Q73814818 | ||
| Initial default from tuberculosis treatment: how often does it happen and what are the reasons? | Q81432304 | ||
| TB in the elderly in industrialised countries | Q81495334 | ||
| Evolution and patterns of global health financing 1995-2014: development assistance for health, and government, prepaid private, and out-of-pocket health spending in 184 countries | Q31954044 | ||
| A systematic review of delay in the diagnosis and treatment of tuberculosis | Q33314674 | ||
| Barriers to accessing TB diagnosis for rural-to-urban migrants with chronic cough in Chongqing, China: a mixed methods study | Q33373181 | ||
| Sexual inequality in tuberculosis | Q33520199 | ||
| Evidence for waning of latency in a cohort study of tuberculosis | Q33533653 | ||
| Delays in diagnosis and treatment of pulmonary tuberculosis in India: a systematic review | Q33806289 | ||
| Incidence of multidrug-resistant tuberculosis disease in children: systematic review and global estimates | Q33889335 | ||
| Tuberculosis and diabetes mellitus: convergence of two epidemics | Q34156234 | ||
| Systematic review and meta-analysis of the associations between indoor air pollution and tuberculosis | Q34310230 | ||
| Socio economic position in TB prevalence and access to services: results from a population prevalence survey and a facility-based survey in Bangladesh. | Q34427810 | ||
| Linkage to care and treatment for TB and HIV among people newly diagnosed with TB or HIV-associated TB at a large, inner city South African hospital | Q34558087 | ||
| Analysis of tuberculosis prevalence surveys: new guidance on best-practice methods. | Q35001454 | ||
| Performance of physician-certified verbal autopsies: multisite validation study using clinical diagnostic gold standards | Q35178967 | ||
| Towards tuberculosis elimination: an action framework for low-incidence countries | Q35344151 | ||
| The relationship between malnutrition and tuberculosis: evidence from studies in humans and experimental animals | Q35771297 | ||
| The relation between different dimensions of alcohol consumption and burden of disease: an overview | Q35835324 | ||
| Modeling causes of death: an integrated approach using CODEm | Q35860880 | ||
| Alcohol's contribution to compromised immunity. | Q36038796 | ||
| The burden of HIV: insights from the Global Burden of Disease Study 2010 | Q37109069 | ||
| Alcohol abuse, immunosuppression, and pulmonary infection. | Q37561225 | ||
| Autopsy causes of death in HIV-positive individuals in sub-Saharan Africa and correlation with clinical diagnoses. | Q37823213 | ||
| High initial default in patients with smear-positive pulmonary tuberculosis at a regional hospital in Accra, Ghana | Q38015507 | ||
| Using verbal autopsy to measure causes of death: the comparative performance of existing methods | Q38177002 | ||
| Effect of new tuberculosis diagnostic technologies on community-based intensified case finding: a multicentre randomised controlled trial | Q38929539 | ||
| Mandatory tuberculosis case notification in high tuberculosis-incidence countries: policy and practice | Q39204953 | ||
| Global burden of drug-resistant tuberculosis in children: a mathematical modelling study | Q39656363 | ||
| Cigarette smoking impairs human pulmonary immunity to Mycobacterium tuberculosis | Q41666071 | ||
| The Challenge of Latent TB Infection | Q42320525 | ||
| Tuberculosis 2000-2010: control, but not elimination | Q43759582 | ||
| Tuberculosis and substance abuse in the United States, 1997-2006. | Q45931262 | ||
| Delayed tuberculosis diagnosis and tuberculosis transmission. | Q51921516 | ||
| Biological differences between the sexes and susceptibility to tuberculosis. | Q53147765 | ||
| Does smoking explain sex differences in the global tuberculosis epidemic? | Q57941839 | ||
| P433 | issue | 3 | |
| P921 | main subject | Global Burden of Disease | Q499419 |
| tuberculosis | Q12204 | ||
| P304 | page(s) | 261-284 | |
| P577 | publication date | 2017-12-07 | |
| P1433 | published in | Lancet Infectious Diseases | Q15724248 |
| P1476 | title | The global burden of tuberculosis: results from the Global Burden of Disease Study 2015 | |
| P478 | volume | 18 |
| Q93047544 | A Model Based on the Combination of IFN-γ, IP-10, Ferritin and 25-Hydroxyvitamin D for Discriminating Latent From Active Tuberculosis in Children |
| Q88970210 | A dual purpose for household contact investigations: preventing TB disease and improving diabetes outcomes |
| Q91844709 | Abdominal tuberculosis in children: A real-world experience of 218 cases from an endemic region |
| Q93165684 | Aftermath of pulmonary tuberculosis: computed tomography assessment |
| Q57808604 | Alma-Ata at 40 years: reflections from the Lancet Commission on Investing in Health |
| Q63859427 | Anthranilic amide and imidazobenzothiadiazole compounds disrupt Mycobacterium tuberculosis membrane potential |
| Q92626530 | Association between vitamin D and latent tuberculosis infection in the United States: NHANES, 2011-2012 |
| Q93012045 | Association of iron deficiency anemia with tuberculosis in Taiwan: A nationwide population-based study |
| Q93117644 | Clinical Profile and Treatment Response of Patients with Ocular Inflammation due to Presumed Ocular Tuberculosis: A Retrospective Study |
| Q99596897 | Co-existence of diabetes and TB among adults in India: a study based on National Family Health Survey data |
| Q98940152 | Diagnostic Potential of a PPE Protein Derived from Mycobacterium tuberculosis Beijing/K Strain |
| Q92146708 | Epidemiology and disease burden of tuberculosis in south of Tunisia over a 22-year period: Current trends and future projections |
| Q91720196 | Global burden of melioidosis in 2015: a systematic review and data synthesis |
| Q58093345 | Global variation in bacterial strains that cause tuberculosis disease: a systematic review and meta-analysis |
| Q59545413 | Global, regional, and national burden of tuberculosis, 1990-2016: results from the Global Burden of Diseases, Injuries, and Risk Factors 2016 Study |
| Q57490745 | Household fuel use and pulmonary tuberculosis in western Nepal: A case-control study |
| Q60044348 | Impact of Xpert MTB/RIF and decentralized care on linkage to care and drug-resistant tuberculosis treatment outcomes in Johannesburg, South Africa |
| Q57470981 | Infectious uveitis: an Asian perspective |
| Q57284626 | Macrophage-targeted drugamers with enzyme-cleavable linkers deliver high intracellular drug dosing and sustained drug pharmacokinetics against alveolar pulmonary infections |
| Q58568707 | Malaria, tuberculosis and HIV: what's new? Contribution of the Institut Hospitalo-Universitaire Méditerranée Infection in updated data |
| Q64987692 | Mapping tuberculosis treatment outcomes in Ethiopia. |
| Q89497865 | Mortality Among People With HIV Treated for Tuberculosis Based on Positive, Negative, or No Bacteriologic Test Results for Tuberculosis: The IeDEA Consortium |
| Q91796753 | Mortality during treatment for tuberculosis; a review of surveillance data in a rural county in Kenya |
| Q60046030 | Multi-drug resistant in Port Harcourt, Nigeria |
| Q93189840 | Mycobacterium tuberculosis Primary Infection and Dissemination: A Critical Role for Alveolar Epithelial Cells |
| Q89997913 | Mycobacterium tuberculosis WhiB3 maintains redox homeostasis and survival in response to reactive oxygen and nitrogen species |
| Q57095547 | Mycobacterium tuberculosis cording in alveolar macrophages of patients with pulmonary tuberculosis is likely associated with increased mycobacterial virulence |
| Q91316150 | Mycobacterium tuberculosis with different virulence reside within intact phagosomes and inhibit phagolysosomal biogenesis in alveolar macrophages of patients with pulmonary tuberculosis |
| Q92644218 | Overweight, Obesity, and Older Age Favor Latent Tuberculosis Infection among Household Contacts in Low Tuberculosis-Incidence Settings within Panama |
| Q64122954 | Prevalence of Auto-antibodies in Pulmonary Tuberculosis |
| Q91810063 | PrimeStore MTM and OMNIgene Sputum for the Preservation of Sputum for Xpert MTB/RIF Testing in Nigeria |
| Q58762206 | Progress toward eliminating TB and HIV deaths in Brazil, 2001-2015: a spatial assessment |
| Q60927283 | Protocol for systematic review and meta-analysis of treatment success rate among adult patients with tuberculosis in sub-Saharan Africa |
| Q64232280 | Realizing the World Health Organization's End TB Strategy (2016⁻2035): How Can Social Approaches to Tuberculosis Elimination Contribute to Progress in Asia and the Pacific? |
| Q64093658 | Simultaneous Adalimumab and Antitubercular Treatment for Latent Tubercular Infection: An Experience from Nepal |
| Q61810045 | Spatial and temporal projections of the prevalence of active tuberculosis in Cambodia |
| Q91722788 | Spatial patterns of tuberculosis and HIV co-infection in Ethiopia |
| Q64101314 | Sub-national prevalence survey of tuberculosis in rural communities of Ethiopia |
| Q95642095 | The Gap Between Global Tuberculosis Incidence and the First Milestone of the WHO End Tuberculosis Strategy: An Analysis Based on the Global Burden of Disease 2017 Database |
| Q89733972 | The association between internal migration and pulmonary tuberculosis in China, 2005-2015: a spatial analysis |
| Q92172667 | The characteristics of spatial-temporal distribution and cluster of tuberculosis in Yunnan Province, China, 2005-2018 |
| Q63246564 | The double burden of diabetes and global infection in low and middle-income countries |
| Q89471991 | The impact of alcohol use on tuberculosis treatment outcomes: a systematic review and meta-analysis |
| Q60914138 | The present state of the tuberculosis drug development pipeline |
| Q92134984 | Trends and risk factors for death and excess all-cause mortality among notified tuberculosis patients in the UK: an analysis of surveillance data |
| Q58563905 | Trends in incidence and mortality of tuberculosis in Japan: a population-based study, 1997-2016 |
| Q92572130 | Tuberculosis |
| Q90644211 | Tuberculosis deaths are predictable and preventable: Comprehensive assessment and clinical care is the key |
| Q57253378 | Tuberculosis disease burden and attributable risk factors in Nigeria, 1990-2016 |
| Q89456938 | What if They Don't Have Tuberculosis? The Consequences and Trade-offs Involved in False-positive Diagnoses of Tuberculosis |
| Q92358398 | [Prevalence of comorbidity tuberculosis and diabetes mellitus in Paraguay, 2016 and 2017Prevalência de comorbidade tuberculose-diabetes mellitus no Paraguai, 2016 e 2017] |
Search more.